Bart C. De Jonghe, PhD, on Inflammation, Obesity and Cancer

Video

Bart C. De Jonghe, PhD, assistant professor, School of Nursing, University of Pennsylvania, discusses inflammation, obesity and cancer.

Bart C. De Jonghe, PhD, assistant professor, School of Nursing, University of Pennsylvania, discusses inflammation, obesity and cancer.

De Jonghe says when a cancer patient is obese and undergoing treatment, it can create a “perfect inflammatory storm.” Current research is looking to see which pathways are affected by obesity and cancer and if any of the inflammatory responses overlap.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Photo of a woman with red hair and glasses wearing a black blouse and cross necklace in front of a dark blue background
Photo of a woman with brown hair and bangs, surrounded by a blue border
Photo of an open bottle of pills
4 experts in this video
Related Content
Photo of a woman with brown hair and bangs, surrounded by a blue border

AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

Michelle Kirschner, RN, MSN, ACNP, APRN-BC
August 4th 2025
Article

Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.

Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers

Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers

Lindsay Fischer
August 4th 2025
Podcast

In this episode of "The Vitals," Sarah Donahue, MPH, NP, AOCNP; Jamie Carroll, APRN, CNP, MSN; Theresa Wicklin Gillespie, PhD, MA, RN, FAAN; and Elizabeth Prechtel-Dunphy, DNP, RN, ANP-BC, AOCN, exchange clinical pearls for treating patients receiving antibody-drug conjugates.

lung cancer

Adagrasib vs Sotorasib: How Do They Compare for Patients With KRAS G12C– Mutated NSCLC?

Linda Childers
August 4th 2025
Article

New targeted therapies offer certain patients with non–small cell lung cancer more second-line treatment options.

lung cancer

Should You Wait for NGS Results Before Initiating NSCLC Treatment?

Lindsay Fischer
August 4th 2025
Article

Beth Sandy, MSN, CRNP, and Tajuana Bradley, MSN, APRN-BC, discuss the importance of molecular testing in non–small cell lung cancer.

bell © New Africa

Is It Time to Rethink the Bell Ringing Ceremony in Cancer Care?

Lindsay Fischer
August 4th 2025
Article

Lindsey Zinck, PhD, RN, OCN, NEA-BC, and Melania Zisa, RN, BSN, OCN, discuss why it may be time to make the bell ringing ceremony a more inclusive celebration in cancer care.

blood cells

Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML

Jordyn Sava
August 4th 2025
Article

Quizartinib plus standard intensive induction and consolidation therapy was associated with longer survival rates in patients with FLT3-ITD–positive acute myeloid leukemia.